Skip to main content

 

Main menu

  • Home
  • Articles
    • Current Issue
    • Archive
    • Most Read
    • On The Horizon Collection
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Services
    • Email Alerts
    • RSS Feeds
  • More
    • AAI Disclaimer
    • Feedback
  • Other Publications
    • American Association of Immunologists
    • The Journal of Immunology

User menu

  • Log in

Search

  • Advanced search
ImmunoHorizons
  • Other Publications
    • American Association of Immunologists
    • The Journal of Immunology
  • Log in
ImmunoHorizons

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Archive
    • Most Read
    • On The Horizon Collection
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Services
    • Email Alerts
    • RSS Feeds
  • More
    • AAI Disclaimer
    • Feedback
  • Follow ImmunoHorizons on Twitter
  • Follow ImmunoHorizons on RSS

About the Cover

September 1, 2020; Volume 4,Issue 9

Cover image

Cover image expansion

On the cover: Pseudomonas aeruginosa is a Gram-negative bacteria and common pathogen that infects the lungs of patients with cystic fibrosis. Lung macrophages are the first line of defense in the airway innate immune response to pathogens. The scanning electron microscopy image (pseudocolored) shows P. aeruginosa (purple) being enveloped and phagocytized by cell surface ruffles of a lung macrophage (blue). Image credit: D. A. Armstrong, L. Howard, and A. Zhang (2019). Armstrong, D. A., M. K. Lee, H. F. Hazlett, J. A. Dessaint, D. L. Mellinger, D. S. Aridgides, G. M. Hendricks, M. A. K. Abdalla, B. C. Christensen and A. Ashare. 2020. Extracellular vesicles from Pseudomonas aeruginosa suppress MHC-related molecules in human lung macrophages. ImmunoHorizons 4: 508–519.

Back to top
PreviousNext
PreviousNext

This Issue

ImmunoHorizons: 4 (9)
ImmunoHorizons
Vol. 4, Issue 9
1 Sep 2020
  • Table of Contents
  • About the Cover
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • Adaptive Immunity
  • Infectious Disease
  • Innate Immunity

  • Highlights
Loading
ImmunoHorizons, a New Home for Immunology Research
T Cell Metabolism Is Dependent on Anatomical Location within the Lung
Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes
Genome-Wide Transcriptional Analysis Reveals Novel AhR Targets That Regulate Dendritic Cell Function during Influenza A Virus Infection
Characterization of γδ T Cell Effector/Memory Subsets Based on CD27 and CD45R Expression in Response to Mycobacterium bovis Infection
Deficiency of Mucosal-Associated Invariant T Cells in TCRJα18 Germline Knockout Mice

Navigate

  • Home
  • Current Issue
  • Archive

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds

Copyright© 2021 by The American Association of Immunologists, Inc

Online ISSN 2573-7732